Pamela Ludwick Siegel
About Pamela Ludwick Siegel
Pamela Ludwick Siegel is the Manager of Stability at Bristol-Myers Squibb in Summit, NJ, with over 20 years of experience in the pharmaceutical industry.
Current Role at Bristol-Myers Squibb
Pamela Ludwick Siegel currently serves as Manager, Stability at Bristol-Myers Squibb in Summit, NJ. In this role, she is responsible for overseeing stability testing processes and ensuring the quality and efficacy of pharmaceutical products. Her extensive experience in stability management contributes significantly to the organization's drug development efforts.
Previous Experience at Celgene
Before joining Bristol-Myers Squibb, Pamela worked at Celgene in various roles related to stability and biologics development. She served as Manager, Stability Biologics Development from 2018 to 2019 in Summit, NJ, and as Specialist, Stability from 2009 to 2018. During her tenure at Celgene, she focused on developing biologic products and conducted extensive stability testing, ensuring compliance with regulatory standards.
Career at Roche
Pamela spent eight years at Roche as a Scientist from 2001 to 2009. Her work primarily involved conducting scientific research and contributing to the development of pharmaceutical products. Her experience at Roche helped her build a solid foundation in the field of pharmaceuticals and added to her expertise in stability testing and development.
Position at US Pharmacopeia
From 1994 to 2001, Pamela held the position of Senior Scientist II at US Pharmacopeia. During her seven-year tenure, she played a crucial role in the development of pharmaceutical standards. Her work at US Pharmacopeia laid the groundwork for her future roles and established her as an expert in pharmaceutical stability testing.
Educational Background
Pamela Ludwick Siegel attended DePauw University, where she gained the educational foundation for her successful career in the pharmaceutical industry. Her academic background, combined with over 20 years of industry experience, has equipped her with the expertise necessary to excel in the fields of stability and biologics development.